Electronic Submission for Changes to OTC Monographs?

The US Food and Drug Administration (FDA) would like to accelerate the over-the-counter (OTC) review process and finalise pending monographs as quickly as possible. To that end, they are seeking passage by Congress of The OTC Monograph User Fee Progr …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news